Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine if Warfarin is affected by PA21.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vifor Pharma
NCT05558150 · Drug Interaction Potentiation
NCT03886701 · Latent Tuberculosis, Human Immunodeficiency Virus, and more
NCT03801746 · Drug Interaction Potentiation
NCT03011463 · Pharmacokinetics, Inhibition Enzyme, and more
NCT02191358 · Adverse Drug Events, Adverse Drug Reactions, and more
PRA International - Clinical Pharmacology Center
Lenexa, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions